在肾脏集合管表达活性B-Raf原癌基因可诱导正常小鼠囊肿形成并加速多囊肾病小鼠囊肿生长
该研究通过构建在集合管条件性表达BRAFV600E的转基因小鼠,发现活性BRAF足以诱导正常小鼠肾脏囊肿形成,并加速Pkd1RC/RC与pcy/pcy两种多囊肾病模型的囊肿生长、纤维化及肾功能下降。
要点
- 集合管表达BRAFV600E的BRafCD小鼠最早3周龄出现肾脏囊肿。
- BRafCD小鼠10周龄时出现广泛肾纤维化及血尿素氮升高。
- 在Pkd1RC/RC与pcy/pcy小鼠中表达活性BRAF加重囊肿负荷并加速肾功能下降。
核心结论
- 活性BRAF足以诱导正常小鼠肾脏囊肿形成,并加速多囊肾病小鼠的囊性疾病进展。
研究设计与样本
- 研究通过将条件性表达BRAFV600E的转基因小鼠与Pkhd1-Cre小鼠交配,在集合管表达活性BRAF,并进一步与Pkd1RC/RC和pcy/pcy两种多囊肾病模型小鼠交配。
主要发现
- BRafCD小鼠最早3周龄出现肾脏囊肿,伴有磷酸化ERK(p-ERK)和增殖细胞核抗原水平升高。
- BRafCD小鼠10周龄时出现广泛肾纤维化和血尿素氮升高,提示肾功能下降。
- 在Pkd1RC/RC和pcy/pcy小鼠中集合管表达活性BRAF显著增加肾脏重量/体重比、囊肿数目和大小及总囊性面积。
- 两种多囊肾病模型中均可见p-ERK水平和增殖细胞增加、免疫细胞浸润、间质纤维化及肾功能下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polycystic kidney disease (PKD) is characterized by the formation and progressive enlargement of fluid-filled cysts due to abnormal cell proliferation. Cyclic AMP agonists, including arginine vasopressin, stimulate ERK-dependent proliferation of cystic cells, but not normal kidney cells. Previously, B-Raf proto-oncogene (BRAF), a MAPK kinase kinase that activates MEK-ERK signaling, was shown to be a central intermediate in the cAMP mitogenic response. However, the role of BRAF on cyst formation and enlargement in vivo had not been demonstrated. To determine if active BRAF induces kidney cyst formation, we generated transgenic mice that conditionally express BRAFV600E, a common activating mutation, and bred them with Pkhd1-Cre mice to express active BRAF in the collecting ducts, a predominant site for cyst formation. Collecting duct expression of BRAFV600E (BRafCD) caused kidney cyst formation as early as three weeks of age. There were increased levels of phosphorylated ERK (p-ERK) and proliferating cell nuclear antigen, a marker for cell proliferation. BRafCD mice developed extensive kidney fibrosis and elevated blood urea nitrogen, indicating a decline in kidney function, by ten weeks of age. BRAFV600E transgenic mice were also bred to Pkd1RC/RC and pcy/pcy mice, well-characterized slowly progressive PKD models. Collecting duct expression of active BRAF markedly increased kidney weight/body weight, cyst number and size, and total cystic area. There were increased p-ERK levels and proliferating cells, immune cell infiltration, interstitial fibrosis, and a decline in kidney function in both these models. Thus, our findings demonstrate that active BRAF is sufficient to induce kidney cyst formation in normal mice and accelerate cystic disease in PKD mice.
引用
- Parnell SC, Raman A, Zhang Y, et al. Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease. Kidney Int. 2022. PMID: 35760151. doi:10.1016/j.kint.2022.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。